In a national study that included 9 million Americans, researchers found that the hospital a patient experiencing post-surgical complications returns to for readmission has an impact on the quality of care the patient receives.
Hospital readmissions are common for patients with complications who undergo major surgeries—nearly a quarter of patients are readmitted within 90 days of the procedure. In a national study that included 9 million Americans, researchers found that the hospital a patient returns to for readmission has an impact on the quality of care the patient receives.
The study, published in The Lancet, found that patients readmitted to the hospital with complications after a major surgery were 26% more likely to survive if they returned to the same hospital from which they received the surgery. Researchers took into account certain measures of surgical quality that can affect mortality, such as hospital size, teaching status, and volume of procedures, when analyzing the results as well as incorporated instrumental variable analyses to eliminate any potential unmeasured bias.
“With up to one in four patients hospitalized following complex surgery, our results could potentially translate into thousands of lives saved every year in the USA alone if patients returned to the hospital where they had the procedure and received care from their original surgical team,” Benjamin Brooke, MD, PhD, of the University of Utah School of Medicine, said in a statement.
The researchers also noted that many patients travel far distances to have their operations done at certain hospitals because the facility is either well-known for providing high-quality care or is a better option in terms of costs with health insurers.
“The assumption has been that if patients need readmission for complications they can seek care at local hospitals without compromising outcomes,” Dr Brooke said in a statement. “However, our findings suggest that maintaining continuity of care when readmissions occur is a more important predictor of survival than other established surgical quality measures.”
The report also found that 65.8% of patients who received coronary artery bypass grafting needed to be readmitted to the hospital within 30 days of the procedure in addition to 82% of patients who had colectomy procedures within the same timeframe. Researchers suggest that the findings might have important implications for cost effectiveness-driven regional centralization of surgical care, as the findings contradict health policies in practice today.
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
FIT Completion, Yield Rates in CRC Screening Similar After New Screening Guidelines
October 22nd 2024Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and 50 years, making screening for colorectal cancer (CRC) effective in younger patients.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More